The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
about
Prognosis and delay of diagnosis among Kaposi's sarcoma patients in Uganda: a cross-sectional study.Kaposi's sarcoma in HIV-infected patients: treatment options.Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.The Role of Type 2 Diabetes for the Development of Pathogen-Associated Cancers in the Face of the HIV/AIDS Epidemic.
P2860
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
description
article
@en
im Mai 1999 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 1999
@uk
name
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
@en
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
@nl
type
label
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
@en
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
@nl
prefLabel
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
@en
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
@nl
P2093
P2860
P1476
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
@en
P2093
J M Huraux
J P Escande
M Grandadam
V Rubin De Cervens
P2860
P304
P356
10.1046/J.1365-2133.1999.02818.X
P407
P577
1999-05-01T00:00:00Z